Enrofloxacin/OVA is an antigen-adjuvant conjugate of Enrofloxacin with ovalbumin (OVA). Conjugating an antigen with a protein adjuvant enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not affect protein folding or alter major epitopes, while enhancing cross-presentation and the generation of antigen-specific T cells.